DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Sai Life Sciences Limited — Alteration Of Capital and Fund Raising-XBRL

NSE 5 hrs ago·5 Nov 2026, 5:44 pm

SAI Life Sciences

Sai Life Sciences has informed stock exchanges about the allotment of new securities. This regulatory filing indicates the company has issued additional shares or warrants, likely to raise fresh capital for its business operations.

For investors, this development is generally viewed positively as it suggests the company is seeking funds to support growth, expansion, or debt reduction. However, the specific purpose of the funds and the dilution of existing shareholders' ownership percentage will be key factors to consider.

Investors should monitor the company's future announcements to understand the exact use of these proceeds. Keeping an eye on how this capital is deployed will be crucial in assessing the long-term impact on the company's financial health and stock performance.